观察“腧穴局解选穴法”针刺治疗对中风后吞咽障碍患者舌咽肌群功能恢复的疗效

注册号:

Registration number:

ITMCTR2024000857

最近更新日期:

Date of Last Refreshed on:

2024-12-22

注册时间:

Date of Registration:

2024-12-22

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

观察“腧穴局解选穴法”针刺治疗对中风后吞咽障碍患者舌咽肌群功能恢复的疗效

Public title:

Investigating the Effectiveness of "Localized Point Selection Method for Acupuncture Treatment" on Restoring the Function of the Tongue and Pharyngeal Muscle Groups in Patients with Post-stroke Dysphagia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

观察“腧穴局解选穴法”针刺治疗对中风后吞咽障碍患者舌咽肌群功能恢复的疗效

Scientific title:

Investigating the Effectiveness of "Localized Point Selection Method for Acupuncture Treatment" on Restoring the Function of the Tongue and Pharyngeal Muscle Groups in Patients with Post-stroke Dysphagia

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈韵瑶

研究负责人:

陈韵瑶

Applicant:

Yunyao Chen

Study leader:

Yunyao Chen

申请注册联系人电话:

Applicant telephone:

15071383019

研究负责人电话:

Study leader's telephone:

15071383019

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

15071383019@163.com

研究负责人电子邮件:

Study leader's E-mail:

15071383019@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

武汉市青山区普仁医院

研究负责人通讯地址:

武汉市青山区普仁医院

Applicant address:

Puren Hospital Qingshan District Wuhan

Study leader's address:

Puren Hospital Qingshan District Wuhan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

武汉市普仁医院

Applicant's institution:

Wuhan Puren Hospital

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

MR-42-24-044901

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

武汉市普仁医院医学伦理委员会

Name of the ethic committee:

Wuhan Puren Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2024/9/29 0:00:00

伦理委员会联系人:

王晓景

Contact Name of the ethic committee:

Wang Xiaojing

伦理委员会联系地址:

武汉市青山区本溪街1号

Contact Address of the ethic committee:

No.1 Benxi Street Qingshan District Wuhan

伦理委员会联系人电话:

Contact phone of the ethic committee:

027-86360020

伦理委员会联系人邮箱:

Contact email of the ethic committee:

799031222@qq.com

研究实施负责(组长)单位:

武汉市普仁医院

Primary sponsor:

Wuhan Puren Hospital

研究实施负责(组长)单位地址:

武汉市普仁医院

Primary sponsor's address:

Wuhan Puren Hospital

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北省

市(区县):

武汉市

Country:

China

Province:

Hubei Province

City:

Wuhan City

单位(医院):

武汉市普仁医院

具体地址:

武汉市青山区本溪街1号

Institution
hospital:

Wuhan Puren Hospital

Address:

No.1 Benxi Street Qingshan District Wuhan

经费或物资来源:

武汉市卫健委

Source(s) of funding:

Wuhan Municipal Health Commission

研究疾病:

中风后吞咽障碍

研究疾病代码:

Target disease:

Dysphagia after stroke

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

评估经腧穴局解选穴法治疗的中风后吞咽障碍患者临床治疗的有效性,为临床治疗提供新思路、新方法,为在临床工作中推广进行初步指导。并寄希望于进一步阐述针刺治疗在外周神经生理病理中的机制。

Objectives of Study:

To evaluate the effectiveness of the clinical treatment of patients with dysphagia after apoplexy treated by the method of acupoints and points to provide new ideas and new methods for clinical treatment and to provide preliminary guidance for promotion in clinical work. It is also hoped to further elucidate the mechanism of acupuncture treatment in peripheral neurophysiology and pathology.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①年龄40~80岁患者; ②符合中医及现代医学诊断标准; ③首次发病,病程0.5-6个月; ④吞咽功能未完全丧失,洼田饮水试验达2级以上; ⑤可耐受0.5~1h的治疗; ⑥能配合表面肌电检查及吞咽相关的评估; ⑦无其他重大疾病;

Inclusion criteria

① patients aged 40 ~ 80 years old; (2) Meet the diagnostic standards of traditional Chinese medicine and modern medicine; ③ First onset duration of disease 0.5-6 months; ④ The swallowing function was not completely lost and the drinking water test reached level 2 or above; ⑤ can tolerate 0.5 ~ 1h treatment; ⑥ can cooperate with surface electromyography and swallowing related assessment; ⑦ No other major diseases;

排除标准:

①患有严重血液系统疾病,或者肝心肾功能异常; ②有鼻咽喉部肿瘤,慢性感染等病变,有甲状腺疾患; ③针刺部位有感染; ④高级智能明显减退,或者存在精神疾病;

Exclusion criteria:

① suffering from severe blood system diseases or abnormal liver heart and kidney function; ② There are tumors in the nose and throat chronic infections and thyroid diseases; ③ The acupuncture site is infected; (4) Obvious decline in advanced intelligence or the existence of mental illness;

研究实施时间:

Study execute time:

From 2024-12-31

To      2025-12-31

征募观察对象时间:

Recruiting time:

From 2025-01-01

To      2025-12-31

干预措施:

Interventions:

组别:

治疗组

样本量:

45

Group:

Treatment group

Sample size:

干预措施:

腧穴局解选穴法针刺治疗

干预措施代码:

Intervention:

Acupuncture treatment of acupoints and acupoints

Intervention code:

组别:

对照组

样本量:

45

Group:

Control group

Sample size:

干预措施:

常规选穴法针刺治疗

干预措施代码:

Intervention:

Acupuncture treatment with routine acupoint selection

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

湖北省

市(区县):

武汉市

Country:

China

Province:

Hubei Province

City:

Wuhan City

单位(医院):

武汉市普仁医院

单位级别:

三级甲等

Institution/hospital:

Wuhan Puren Hospital

Level of the institution:

Class III Class A

测量指标:

Outcomes:

指标中文名:

吞咽功能相关量表评定

指标类型:

次要指标

Outcome:

Swallowing function correlation scale assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

表面肌电信号平均振幅值、最大波幅和平均时间

指标类型:

主要指标

Outcome:

Average amplitude maximum amplitude and average time of surface EMG signal

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 40
Min age years
最大 80
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

按照数字1-90对90个信封逐个编号,开始时,在随机数字表选择随意的一个数字,然后依次抽取剩下的89个数字,选择数字要在数字表上沿着相同的方向和顺序选。选择数字后,每个数字都除以2,求除法后的余数,能够被2整除的数字列入腧穴局解选穴法组,不能被2整除的数字列入常规选穴法组。然后按照1到90的编号制作随机卡,每张卡片上标注数字的组别和接受的治疗方法,最后装入信封中由专人保存。

Randomization Procedure (please state who generates the random number sequence and by what method):

Number each of the 90 envelopes one by one with the numbers 1-90. Start by selecting a random number in the random number table and then draw the remaining 89 numbers in turn choosing the numbers in the same direction and order on the number table. After the selection of numbers each number is divided by 2 and the remainder after division is obtained. The numbers that can be evenly divided by 2 are included in the acupoint method group and the numbers that cannot be evenly divided by 2 are included in the conventional acupoint method group. Random cards numbered from 1 to 90 were made with each card marked with the number group and the treatment received and finally placed in an envelope for personal storage.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not shared

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

设计标准化病例记录表,涵盖患者基本信息、病史、检查检验、治疗随访等数据。采用专业电子数据采集系统,设置权限管理、实时录入与验证,定期审核清理,做好备份保密,确保数据准确、安全、完整及可追溯。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Standardized case record form was designed to cover basic information medical history examination treatment follow-up and other data of patients. Adopt a professional electronic data acquisition system set up rights management real-time input and verification regularly review and clean up and do a good job of backup confidentiality to ensure data accuracy safety integrity and traceability.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统